MentionFox
Home › funding signals › Elysia Creative Biology, Inc.
Form D · on the record

Elysia Creative Biology — $465K Form D filing, February 2026

Before you sell to, join or invest in Elysia Creative Biology, Inc.

MentionFox check on Elysia Creative Biology, Inc.: only 1 source on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/elysia-creative-biology-inc-form-d-26000001

Check Elysia Creative Biology, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Elysia Creative Biology, Inc.?

Based on the record MentionFox holds for this company. No flag is not a clearance.

Elysia Creative Biology, Inc. filed a Form D with the Securities and Exchange Commission on 2026-02-11.

Elysia Creative Biology, Inc. filed a Form D notice of an exempt securities offering with the SEC on February 11, 2026. The filing reports $465K sold. Its industry group is Biotechnology. It names Eli Hornstein (Executive Officer, Director, Promoter) (SEC Form D, February 11, 2026).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

3 more Biotechnology raises in North Carolina within 90 days ↓

Is this your company?

Key facts

Run the free check on Elysia Creative Biology, Inc. →

Sell to companies like Elysia Creative Biology, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Elysia Creative Biology, Inc.

New Form D on file · 2026-02-11 · the record

$465K
raise on the record
D
filing
3
investors in
NORTH CAROLINA
based
Open the record →

What the record says

FilingForm D
Filed2026-02-11
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
Year formed2024
BasedRALEIGH, NORTH CAROLINA
CIK2102037
Accession0002102037-26-000001

Pitching, partnering or investing alongside them? See who really runs and owns Elysia Creative Biology, Inc.

Watch Elysia Creative Biology, Inc.: email me the next time it files something

Free to see. No signup.

Keep reading

More on the people and the money behind Elysia Creative Biology, Inc., from the filings we hold.

More raises like this

Biotechnology raises by companies based in North Carolina, filed within 90 days of this one, largest first.

What do you want to do with Elysia Creative Biology, Inc.?

Get the full cited report on Elysia Creative Biology, Inc.

What the filing shows about Elysia Creative Biology, Inc.

  • 3 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Elysia Creative Biology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Elysia Creative Biology, Inc.'s address as 840 Oval Drive, Raleigh, NC 27606.

Keep digging

Who else raised the same week in biotechnology

What the filing says

  • Offered: $465,000. Sold: $464,875. Left to sell: $125. (filing)
  • Investors: 3 had already invested. (filing)
  • Date of first sale: August 15, 2025. (filing)
  • Types of securities: Options, warrants or other rights to acquire another security. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters (marked as an estimate). It adds: “Proceeds to be used for working capital, which may include compensation to executive officers in the ordinary course of business.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Elysia Creative Biology, Inc. See pricing

Is Elysia Creative Biology, Inc. a real, registered company?

Elysia Creative Biology, Inc. is a registered filer with the SEC (CIK 2102037) and has filed since 2026-02-11. 1 filing is on record, the latest on 2026-02-11.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Elysia Creative Biology, Inc.?

Elysia Creative Biology, Inc.'s Form D of 2026-02-11 names Eli Hornstein as its officers, directors or promoters.

How much has Elysia Creative Biology, Inc. raised?

Its new offerings report $465K sold across 1 offering, as its own filings state.

Biotechnology · by week
This raise, $465K, filed week of Feb 9

Trailing twelve months. 765 filings in Biotechnology, totalled by week. The dot is this raise, $465K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Elysia Creative Biology, Inc.?

What the filing shows about Elysia Creative Biology, Inc.

  • 3 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Elysia Creative Biology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Elysia Creative Biology, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Elysia Creative Biology, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Elysia Creative Biology, Inc.. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Elysia Creative Biology, Inc.: Raised $465K, Form D filed 2026-02-11
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/elysia-creative-biology-inc-form-d-26000001
Last updated 2026-11-05
Primary record: SEC filing 1 · SEC filing 2
Elysia Creative Biology raised $465K — SEC Form D filing, February 2026. MentionFox, 2026-11-05. https://mentionfox.com/funding/elysia-creative-biology-inc-form-d-26000001